Collaboration Details

Print  Close

Title of Collaborative Activity:

FDA Arthritis Drugs Advisory Committee Meeting

Description of Collaborative Activity:

An NIMH Program Officer (PO) was invited to serve as a voting ad hoc member of one of the FDA Arthritis Drugs Advisory Committees, which met to review a new drug application for the treatment of Chronic Fatigue Syndrome (CFS). Subsequently, the NIMH PO has been invited as the sole NIH representative to a follow-up meeting planned at the FDA among FDA staff, a CDC representative, and the sponsor to discuss further steps in Myalgic Encephalomyelitis/CFS drug development.

Type of Collaborative Activity:

Meeting/ Workshop

Year the Collaborative Activity Originated:


NIH Participating Institutes/Centers/Office of the Director:


HHS Agency Collaborators on this Activity: